Litcius/Paper detail

EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research

Ruifang Dong, Miaolin Zhu, Mingming Liu, Yiting Xu, Liu-Liu Yuan, Jing Bian, Yuan‐Zheng Xia, Lingyi Kong

2021Pharmacological Research200 citationsDOI

Topics & Concepts

T790MEpidermal growth factor receptorLung cancerMedicineTargeted therapyCancer researchTyrosine kinaseEGFR inhibitorsOsimertinibMutationDrug resistanceGefitinibErlotinibCancerOncologyBiologyInternal medicineReceptorGeneticsGeneLung Cancer Treatments and MutationsCancer therapeutics and mechanismsColorectal Cancer Treatments and Studies